The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
Abstract
Objective. To develop a set of disease activity measures for use in rheumatoid arthritis (RA) clinical trials, as well as to recommend specific methods for assessing each outcome measure. This is not intended to be a restrictive list, but rather, a core set of measures that should be included in all trials. Methods. We evaluated disease activity measures commonly used in RA trials, to determine which measures best met each of 5 types of validity: construct, face, content, criterion, and discriminant. The evaluation consisted of an initial structured review of the literature on the validity of measures, with an analysis of data obtained from clinical trials to fill in gaps in this literature. A committee of experts in clinical trials, health services research, and biostatistics reviewed the validity data. A nominal group process method was used to reach consensus on a core set of disease activity measures. This set was then reviewed and finalized at an international conference on outcome measures for RA clinical trials. The committee also selected specific ways to assess each outcome. Results. The core set of disease activity measures consists of a tender joint count, swollen joint count, patient's assessment of pain, patient's and physician's global assessments of disease activity, patient's assessment of physical function, and laboratory evaluation of 1 acute‐phase reactant. Together, these measures sample the broad range of improvement in RA (have content validity), and all are at least moderately sensitive to change (have discriminant validity). Many of them predict other important long‐term outcomes in RA, including physical disability, radiographic damage, and death. Other disease activity measures frequently used in clinical trials were not chosen for any one of several reasons, including insensitivity to change or duplication of information provided by one of the core measures (e.g., tender joint score and tender joint count) The committee also proposes specific ways of measuring each outcome. Conclusion. We propose a core set of outcome measures for RA clinical trials. We hope this will decrease the number of outcomes assessed and standardize outcomes assessments. Further, we hope that these measures will be found useful in long‐term studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes
(1976) · The Journal of Applied Behavioral Science · doi:10.1177/002188637601200414 · Cited by 2,813
(1968) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067150 · Cited by 1,349
Measuring health status in arthritis
Meenan, R. F., Gertman, P. M., & Mason, J. H. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230203 · Cited by 1,176
van der Heijde, D. M., van 't Hof, M. A., van Riel, P. L., Theunisse, L. A., Lubberts, E. W., van Leeuwen, M. A., van Rijswijk, M. H., & van de Putte, L. B. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.11.916 · Cited by 1,087
Pincus, T., Callahan, L. F., Sale, W. G., Brooks, A. L., Payne, L. E., & Vaughn, W. K. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270805 · Cited by 760
The Effectiveness of Nominal, Delphi, and Interacting Group Decision Making Processes.
Van de, A. H., & Delbecq, A. L. (1974) · Academy of Management Journal · doi:10.2307/255641 · Cited by 695
Survival, prognosis, and causes of death in rheumatoid arthritis
Mitchell, D. M., Spitz, P. W., Young, D. Y., Bloch, D. A., McShane, D. J., & Fries, J. F. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290602 · Cited by 431
Tugwell, P., Bombardier, C., Buchanan, W. W., Goldsmith, C. H., Grace, E. M., & Hanna, B. (1987) · PubMed · Cited by 390
Self-citationBombardier, C., Ware, J., Russell, I. J., Larson, M., Chalmers, A., Read, J. L., Arnold, W., Bennett, R., Caldwell, J., Hench, P. K., et al. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90539-5 · Cited by 359
Self-citationvan der Heijde, D. M., van't Hof, M. A., van Riel, P. L., van Leeuwen, M. A., van Rijswijk, M. H., & van de Putte, L. B. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.2.177 · Cited by 325
Cited by
Prevoo, M. L. L., Van'T Hof, M. A., Kuper, H. H., Van Leeuwen, M. A., Van De Putte, L. B. A., & Van Riel, P. L. C. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380107 · Cited by 6,243
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Self-citationAmerican college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Self-citationEfficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Treating rheumatoid arthritis to target: recommendations of an international task force
Smolen, J. S., Aletaha, D., Bijlsma, J. W. J., Breedveld, F. C., Boumpas, D., Burmester, G., Combe, B., Cutolo, M., de Wit, M., Dougados, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.123919 · Cited by 2,100
Weinblatt, M. E., Kremer, J. M., Bankhurst, A. D., Bulpitt, K. J., Fleischmann, R. M., Fox, R. I., Jackson, C. G., Lange, M., & Burge, D. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400401 · Cited by 2,085
Self-citationConsensus development methods, and their use in clinical guideline development.
Murphy, Black, Lamping, McKee, Sanderson, Askham, & Marteau (1998) · Health Technology Assessment · doi:10.3310/hta2030 · Cited by 2,051
Weinblatt, M. E., Keystone, E. C., Furst, D. E., Moreland, L. W., Weisman, M. H., Birbara, C. A., Teoh, L. A., Fischkoff, S. A., & Chartash, E. K. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10697 · Cited by 1,757
Self-citationElliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Guidelines for the management of rheumatoid arthritis: 2002 Update
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) · Arthritis & Rheumatism · doi:10.1002/art.10148 · Cited by 1,185
Keystone, E. C., Kavanaugh, A. F., Sharp, J. T., Tannenbaum, H., Hua, Y., Teoh, L. S., Fischkoff, S. A., & Chartash, E. K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20217 · Cited by 1,172
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. A., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,127
Self-citationA simplified disease activity index for rheumatoid arthritis for use in clinical practice
Smolen, J. S., Breedveld, F. C., Schiff, M. H., Kalden, J. R., Emery, P., Eberl, G., van Riel, P. L., & Tugwell, P. (2003) · Rheumatology · doi:10.1093/rheumatology/keg072 · Cited by 1,071
Self-citationAletaha, D., Nell, V. P., Stamm, T., Uffmann, M., Pflugbeil, S., Machold, K., & Smolen, J. S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1740 · Cited by 1,068
Preliminary definition of improvement in juvenile arthritis
Giannini, E. H., Ruperto, N., Ravelli, A., Lovell, D. J., Felson, D. T., & Martini, A. (1997) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199707)40:7<1202::aid-art3>3.0.co;2-r · Cited by 1,047
Self-citationTreatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
Therapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
The Disease Activity Score and the EULAR Response Criteria
Fransen, J., & van Riel, P. L. C. M. (2009) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.10.001 · Cited by 877
Genovese, M. C., McKay, J. D., Nasonov, E. L., Mysler, E. F., da Silva, N. A., Alecock, E., Woodworth, T., & Gomez‐Reino, J. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23940 · Cited by 855
Hurst, N. P., Kind, P., Ruta, D., Hunter, M., & Stubbings, A. (1997) · Rheumatology · doi:10.1093/rheumatology/36.5.551 · Cited by 826
Nell, V. P. K. (2004) · Rheumatology · doi:10.1093/rheumatology/keh199 · Cited by 818
Simon, L. S., Weaver, A. L., Graham, D. Y., Kivitz, A. J., Lipsky, P. E., Hubbard, R. C., Isakson, P. C., Verburg, K. M., Yu, S. S., Zhao, W. W., et al. (1999) · JAMA · doi:10.1001/jama.282.20.1921 · Cited by 798
Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., & Kishimoto, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20303 · Cited by 788
Anderson, J., Caplan, L., Yazdany, J., Robbins, M. L., Neogi, T., Michaud, K., Saag, K. G., O'dell, J. R., & Kazi, S. (2012) · Arthritis Care & Research · doi:10.1002/acr.21649 · Cited by 748
Self-citationKremer, J. M., Genant, H. K., Moreland, L. W., Russell, A. S., Emery, P., Abud-Mendoza, C., Szechinski, J., Li, T., Ge, Z., Becker, J.-C., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-12-200606200-00003 · Cited by 715
van de Putte, L. B. A., Atkins, C., Malaise, M., Sany, J., Russell, A. S., van Riel, P. L. C. M., Settas, L., Bijlsma, J. W., Todesco, S., Dougados, M., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.013052 · Cited by 617
Exercise for treating fibromyalgia syndrome
Busch, A. J., Barber, K. A. R., Overend, T. J., Peloso, P. M. J., & Schachter, C. L. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003786.pub2 · Cited by 597
van der Heijde, D., Tanaka, Y., Fleischmann, R., Keystone, E., Kremer, J., Zerbini, C., Cardiel, M. H., Cohen, S., Nash, P., Song, Y., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37816 · Cited by 577
Pavletic, S. Z., Martin, P., Lee, S. J., Mitchell, S., Jacobsohn, D., Cowen, E. W., Turner, M. L., Akpek, G., Gilman, A., McDonald, G., et al. (2006) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2006.01.008 · Cited by 563
Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states
Aletaha, D., Ward, M. M., Machold, K. P., Nell, V. P. K., Stamm, T., & Smolen, J. S. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21235 · Cited by 542
van der Heijde, D., Klareskog, L., Rodriguez‐Valverde, V., Codreanu, C., Bolosiu, H., Melo‐Gomes, J., Tornero‐Molina, J., Wajdula, J., Pedersen, R., Fatenejad, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21655 · Cited by 535
Genovese, M. C., Cohen, S., Moreland, L., Lium, D., Robbins, S., Newmark, R., Bekker, P., & for the 20000223 Study Group (2004) · Arthritis & Rheumatism · doi:10.1002/art.20221 · Cited by 532
Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis
Tugwell, P., Pincus, T., Yocum, D., Stein, M., Gluck, O., Kraag, G., McKendry, R., Tesser, J., Baker, P., & Wells, G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507203330301 · Cited by 530
Self-citationTofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
Gladman, D., Rigby, W., Azevedo, V. F., Behrens, F., Blanco, R., Kaszuba, A., Kudlacz, E., Wang, C., Menon, S., Hendrikx, T., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615977 · Cited by 510
Capturing the Patient's View of Change as a Clinical Outcome Measure
Fischer, D. (1999) · JAMA · doi:10.1001/jama.282.12.1157 · Cited by 483
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
Smolen, J. S., & Aletaha, D. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.8 · Cited by 474
Smolen, J. S., Han, C., Bala, M., Maini, R. N., Kalden, J. R., van der Heijde, D., Breedveld, F. C., Furst, D. E., Lipsky, P. E., & ATTRACT Study Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.20982 · Cited by 462
Self-citationInterstitial Lung Disease in Recent Onset Rheumatoid Arthritis
GABBAY, E., TARALA, R., WILL, R., CARROLL, G., ADLER, B., CAMERON, D., & LAKE, F. R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.9609016 · Cited by 451
Genovese, M. C., Van den Bosch, F., Roberson, S. A., Bojin, S., Biagini, I. M., Ryan, P., & Sloan‐Lancaster, J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27334 · Cited by 451
Emery, P., Breedveld, F. C., Dougados, M., Kalden, J. R., Schiff, M. H., & Smolen, J. S. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.4.290 · Cited by 445
Kremer, J. M., Dougados, M., Emery, P., Durez, P., Sibilia, J., Shergy, W., Steinfeld, S., Tindall, E., Becker, J., Li, T., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21201 · Cited by 444
Naredo, E., Bonilla, G., Gamero, F., Uson, J., Carmona, L., & Laffon, A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023929 · Cited by 443
Smolen, J. S., Van Der Heijde, D. M. F. M., St.Clair, E. W., Emery, P., Bathon, J. M., Keystone, E., Maini, R. N., Kalden, J. R., Schiff, M., Baker, D., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21678 · Cited by 434
Patients' perceptions of fatigue in rheumatoid arthritis: Overwhelming, uncontrollable, ignored
Hewlett, S., Cockshott, Z., Byron, M., Kitchen, K., Tipler, S., Pope, D., & Hehir, M. (2005) · Arthritis Care & Research · doi:10.1002/art.21450 · Cited by 434
Lee, S. J., Wolff, D., Kitko, C., Koreth, J., Inamoto, Y., Jagasia, M., Pidala, J., Olivieri, A., Martin, P. J., Przepiorka, D., et al. (2015) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2015.02.025 · Cited by 431
Systematic review of outpatient services for chronic pain control.
McQuay, Moore, Eccleston, Morley, & Williams (1997) · Health Technology Assessment · doi:10.3310/hta1060 · Cited by 424
Kaltwasser, J. P., Nash, P., Gladman, D., Rosen, C. F., Behrens, F., Jones, P., Wollenhaupt, J., Falk, F. G., & Mease, P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20253 · Cited by 413
Kremer, J. M., Blanco, R., Brzosko, M., Burgos-Vargas, R., Halland, A.-M., Vernon, E., Ambs, P., & Fleischmann, R. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30158 · Cited by 409
Taylor, P. C., Peters, A. M., Paleolog, E., Chapman, P. T., Elliott, M. J., McCloskey, R., Feldmann, M., & Maini, R. N. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<38::aid-anr6>3.0.co;2-l · Cited by 405
Van Ede, A. E., Laan, R. F. J. M., Rood, M. J., Huizinga, T. W. J., Van De Laar, M. A. F. J., Denderen, C. J. V., Westgeest, T. A. A., Romme, T. C., De Rooij, D.-J. R. A. M., Jacobs, M. J. M., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1515::aid-art273>3.0.co;2-7 · Cited by 401
Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission
Molenaar, E. T. H., Voskuyl, A. E., Dinant, H. J., Bezemer, P. D., Boers, M., & Dijkmans, B. A. C. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11481 · Cited by 384
Self-citationMoreland, L. W., Alten, R., Van Den Bosch, F., Appelboom, T., Leon, M., Emery, P., Cohen, S., Luggen, M., Shergy, W., Nuamah, I., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10294 · Cited by 383
PREVOO, M. L. L., VAN GESTEL, A. M., VAN THOF, M. A., VAN RIJSWIJK, M. H., VAN DE PUTTE, L. B. A., & VAN RIEL, P. L. C. M. (1996) · Rheumatology · doi:10.1093/rheumatology/35.11.1101 · Cited by 373
Kremer, J. M., Genovese, M. C., Cannon, G. W., Caldwell, J. R., Cush, J. J., Furst, D. E., Luggen, M. E., Keystone, E., Weisman, M. H., Bensen, W. M., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-9-200211050-00007 · Cited by 353
Self-citationPINCUS, T., SWEARINGEN, C. J., BERGMAN, M., & YAZICI, Y. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080182 · Cited by 349
Emery, P., Deodhar, A., Rigby, W. F., Isaacs, J. D., Combe, B., Racewicz, A. J., Latinis, K., Abud-Mendoza, C., Szczepański, L. J., Roschmann, R. A., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119933 · Cited by 348
Kremer, J. M., Cohen, S., Wilkinson, B. E., Connell, C. A., French, J. L., Gomez‐Reino, J., Gruben, D., Kanik, K. S., Krishnaswami, S., Pascual‐Ramos, V., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33419 · Cited by 344
Mease, P. J. (2011) · Arthritis Care & Research · doi:10.1002/acr.20577 · Cited by 342
Luo, X., Lynn George, M., Kakouras, I., Edwards, C. L., Pietrobon, R., Richardson, W., & Hey, L. (2003) · Spine · doi:10.1097/01.brs.0000083169.58671.96 · Cited by 323
Guidelines for the management of rheumatoid arthritis
American College of Rheumatology AD Hoc Committee on Clinical Guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390502 · Cited by 329
Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care
Curtis, J. R., & Singh, J. A. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.05.044 · Cited by 326
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis
Kingsley, G. H., Kowalczyk, A., Taylor, H., Ibrahim, F., Packham, J. C., McHugh, N. J., Mulherin, D. M., Kitas, G. D., Chakravarty, K., Tom, B. D. M., et al. (2012) · Rheumatology · doi:10.1093/rheumatology/kes001 · Cited by 322
Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases
Siebert, S., Tsoukas, A., Robertson, J., & McInnes, I. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009639 · Cited by 307
Tak, P. P., Rigby, W. F., Rubbert-Roth, A., Peterfy, C. G., van Vollenhoven, R. F., Stohl, W., Hessey, E., Chen, A., Tyrrell, H., & Shaw, T. M. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137703 · Cited by 307
Cohen, S. B., Moreland, L. W., Cush, J. J., Greenwald, M. W., Block, S., Shergy, W. J., Hanrahan, P. S., Kraishi, M. M., Patel, A., Sun, G., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016014 · Cited by 305
Weisman, M. H., Moreland, L. W., Furst, D. E., Weinblatt, M. E., Keystone, E. C., Paulus, H. E., Teoh, L. S., Velagapudi, R. B., Noertersheuser, P. A., Granneman, G. R., et al. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80164-9 · Cited by 303
Self-citationMladenovic, V., Domljan, Z., Rozman, B., Jajic, I., Mihajlovic, D., Dordevic, J., Popovic, M., Dimitrijevic, M., Zivkovic, M., Campion, G., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381111 · Cited by 303
Gossec, L., Paternotte, S., Aanerud, G. J., Balanescu, A., Boumpas, D. T., Carmona, L., de Wit, M., Dijkmans, B. A. C., Dougados, M., Englbrecht, M., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.142901 · Cited by 291
Weinblatt, M. E., Kremer, J. M., Coblyn, J. S., Maier, A. L., Helfgott, S. M., Morrell, M., Byrne, V. M., Kaymakcian, M. V., & Strand, V. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199907)42:7<1322::aid-anr4>3.0.co;2-p · Cited by 286
Self-citationSmolen, J. S., Eberl, G., Breedveld, F. C., Jones, I., Leeming, M., Wylie, G. L., & Kirkpatrick, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380106 · Cited by 285
Tao, X., Younger, J., Fan, F. Z., Wang, B., & Lipsky, P. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10411 · Cited by 282
Studenic, P., Radner, H., Smolen, J. S., & Aletaha, D. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34543 · Cited by 281
Sleep Loss Exacerbates Fatigue, Depression, and Pain in Rheumatoid Arthritis
Irwin, M. R., Olmstead, R., Carrillo, C., Sadeghi, N., FitzGerald, J. D., Ranganath, V. K., & Nicassio, P. M. (2012) · Sleep · doi:10.5665/sleep.1742 · Cited by 279
Methotrexate for treating rheumatoid arthritis
Lopez-Olivo, M. A., Siddhanamatha, H. R., Shea, B., Tugwell, P., Wells, G. A., & Suarez-Almazor, M. E. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000957.pub2 · Cited by 277
Self-citationAaltonen, K. J., Virkki, L. M., Malmivaara, A., Konttinen, Y. T., Nordström, D. C., & Blom, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030275 · Cited by 273
Nikiphorou, E., Radner, H., Chatzidionysiou, K., Desthieux, C., Zabalan, C., van Eijk-Hustings, Y., Dixon, W. G., Hyrich, K. L., Askling, J., & Gossec, L. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1151-6 · Cited by 270
Clinical Pharmacokinetics and Use??of??Infliximab
Klotz, U., Teml, A., & Schwab, M. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746080-00002 · Cited by 261
Anderson, J. K., Zimmerman, L., Caplan, L., & Michaud, K. (2011) · Arthritis Care & Research · doi:10.1002/acr.20621 · Cited by 260
Self-citationGamma linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial
Zurier, R. B., Rossetti, R. G., Jacobson, E. W., Demarco, D. M., Liu, N. Y., Temming, J. E., White, B. M., & Laposata, M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391106 · Cited by 217
Genovese, M. C., Fleischmann, R., Kivitz, A. J., Rell‐Bakalarska, M., Martincova, R., Fiore, S., Rohane, P., van Hoogstraten, H., Garg, A., Fan, C., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39093 · Cited by 219
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
Abramson, S. B. (2002) · Rheumatology · doi:10.1093/rheumatology/41.9.972 · Cited by 217
Aletaha, D., Landewe, R., Karonitsch, T., Bathon, J., Boers, M., Bombardier, C., Bombardieri, S., Choi, H., Combe, B., Dougados, M., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.24123 · Cited by 214
Self-citationPatient-physician discordance in assessments of global disease severity in rheumatoid arthritis
Barton, J. L., Imboden, J., Graf, J., Glidden, D., Yelin, E. H., & Schillinger, D. (2010) · Arthritis Care & Research · doi:10.1002/acr.20132 · Cited by 191
Powers, J. H., Patrick, D. L., Walton, M. K., Marquis, P., Cano, S., Hobart, J., Isaac, M., Vamvakas, S., Slagle, A., Molsen, E., et al. (2017) · Value in Health · doi:10.1016/j.jval.2016.11.005 · Cited by 191
Fleischmann, R., van Adelsberg, J., Lin, Y., Castelar‐Pinheiro, G. D. R., Brzezicki, J., Hrycaj, P., Graham, N. M. H., van Hoogstraten, H., Bauer, D., & Burmester, G. R. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39944 · Cited by 178
The Definition and Measurement of Disease Modification in Inflammatory Rheumatic Diseases
Aletaha, D., & Smolen, J. S. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2005.09.005 · Cited by 152
Pincus, T., Strand, V., Koch, G., Amara, I., Crawford, B., Wolfe, F., Cohen, S., & Felson, D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10824 · Cited by 146
Self-citationPatient-reported outcomes and their role in the assessment of rheumatoid arthritis
Lubeck, D. P. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422001-00004 · Cited by 123
Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis
Gossec, L., Dougados, M., & Dixon, W. (2015) · RMD Open · doi:10.1136/rmdopen-2014-000019 · Cited by 115
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
Reginster, J.-Y., Cooper, C., Rizzoli, R., Kanis, J. A., Appelboom, G., Bautmans, I., Bischoff-Ferrari, H. A., Boers, M., Brandi, M. L., Bruyère, O., et al. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0517-y · Cited by 112
Self-citationWeinblatt, M. E., Mease, P., Mysler, E., Takeuchi, T., Drescher, E., Berman, A., Xing, J., Zilberstein, M., Banerjee, S., & Emery, P. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39249 · Cited by 98
Self-citationPerformance of health status measures with a pen based personal digital assistant
Kvien, T. K., Mowinckel, P., Heiberg, T., Dammann, K. L., Dale, Ø., Aanerud, G. J., Alme, T. N., & Uhlig, T. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.030437 · Cited by 92
Chopra, A., Saluja, M., & Tillu, G. (2010) · Journal of Ayurveda and Integrative Medicine · doi:10.4103/0975-9476.72620 · Cited by 88
Baron, M., Schieir, O., Hudson, M., Steele, R., Kolahi, S., Berkson, L., Couture, F., Fitzcharles, M. A., Gagné, M., Garfield, B., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23314 · Cited by 77
Cognitive-behavioral treatment in unselected rheumatoid arthritis outpatients
Leibing, E., Pfingsten, M., Bartmann, U., Rueger, U., & Schuessler, G. (1999) · The Clinical Journal of Pain · doi:10.1097/00002508-199903000-00009 · Cited by 67
Paran, D., Elkayam, O., Mayo, A., Paran, H., Amit, M., Yaron, M., & Caspi, D. (2001) · Annals of the Rheumatic Diseases · doi:10.1016/s0003-4967(24)43390-6 · Cited by 56
Lumley, M. A., Keefe, F. J., Mosley-Williams, A., Rice, J. R., McKee, D., Waters, S. J., Partridge, R. T., Carty, J. N., Coltri, A. M., Kalaj, A., et al. (2014) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0036958 · Cited by 41
“The physician evaluated the presence or absence of tenderness and swelling in each of 16 joints bilaterally (5 interphalangeal and 5 metacarpal phalangeal joints in addition to shoulder, elbow, wrist, knee ankle and metatarsals, for a total of 32 joints; Felson et al., 1993).”
Smyth, J. M., Stone, A. A., Hurewitz, A., & Kaell, A. (1999) · JAMA · doi:10.1001/jama.281.14.1304 · Cited by 39
“The primary outcome measure for this study was the physician’s global assessment of patients’ current clinical status, which has been recommended for use in RA clinical trials.(26,27) Each RA patient had 4 clinical examinations completed by the same physician.”
MethodHamy, V., Garcia-Gancedo, L., Pollard, A., Myatt, A., Liu, J., Howland, A., Beineke, P., Quattrocchi, E., Williams, R., & Crouthamel, M. (2020) · Digital Biomarkers · doi:10.1159/000506860 · Cited by 37
Metadata
- Authors
- Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Chernoff, M., Fried, B., Furst, D., Goldsmith, C., Kieszak, S., Lightfoot, R., Paulus, H., Tugwell, P., Weinblatt, M., Widmark, R., James Williams, H., & Wolfe, F.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1993-06
- Volume
- 36
- Issue
- 6
- Pages
- 729-740
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2033299724
- Cited by
- 1,640
- References
- 41
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.